Shape the future of drug discovery
At Almac Discovery, we are driven by curiosity, innovation, and the ambition to deliver breakthrough medicines. As a highly research‑intensive biotech company, we focus on discovering and developing novel therapeutics that have the potential to redefine patient care. Our multidisciplinary team of scientists harnesses cutting‑edge technologies to create first‑in‑class, preclinical assets, which are advanced through strategic partnerships for further development. Innovation is at the heart of everything we do—from target discovery to molecule design.
What truly sets Almac Discovery apart is our deep, integrated expertise in both antibody–drug conjugates (ADCs) and small‑molecule drug discovery. This unique combination enables us to deliver next‑generation ADCs with novel payloads and linker technologies. In parallel, we are pioneering induced‑proximity approaches to tackle emerging, disease‑relevant targets—opening new opportunities for both innovative ADC payloads and first‑in‑class oral therapeutics.
Our teams work from state‑of‑the‑art facilities on the Queen’s University Belfast life sciences campus, strategically located alongside major hospitals and the Northern Ireland Cancer Centre. We are further supported by specialist laboratories in Edinburgh dedicated to ADC development, and a bioinformatics hub in Manchester, UK. If you are passionate about science, collaboration, and pushing the boundaries of drug discovery, we would love to hear from you – Almac Discovery is where bold ideas become transformative medicines.